Filing Flows › BioScience Health Innovations (BHIC) › Operating margin
BioScience Health Innovations (BHIC) operating margin by quarter
BioScience Health Innovations' operating margin was 26.0% in Q2 2025 (second quarter 2025), -8.7 pts from Q1 2025. Over the last 3 quarters it ranged from 1.6% (Q4 2024) to 34.8% (Q1 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2025 | 26.0% | -8.7 pts | — |
| Q1 2025 | 34.8% | +33.2 pts | — |
| Q4 2024 | 1.6% | — | — |
Q2 2025 at a glance
BioScience Health Innovations, Q2 2025: revenue $1.8M (+358% year over year), operating margin 26.0%, net earnings $458K, operating cash flow $285K. The chart follows the revenue to costs, profit and cash.
Questions
What is BioScience Health Innovations' operating margin?
BioScience Health Innovations' operating margin was 26.0% in Q2 2025 (second quarter 2025), -8.7 pts from Q1 2025.
How has BioScience Health Innovations' operating margin changed?
Over the last 3 quarters it ranged from 1.6% (Q4 2024) to 34.8% (Q1 2025).
Q2 2025 results → · How BioScience Health Innovations makes money →